2
Clinical Trials associated with Allogeneic mesenchymal stem cells therapy (Bonus BioGroup)A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS
The efficacy of the allogeneic cell-therapy product MesenCure in addition to standard of care will be evaluated in comparison to placebo control in 300 moderate to severe Covid patients
A Controlled Study to Evaluate the Safety and Efficacy of Allogeneic MesenCure for the Treatment of Pulmonary Manifestations in Patients With COVID19
An open label clinical study to evaluate the safety and the efficacy of MesenCure, an allogeneic cell therapy product, for the treatment of the pulmonary manifestations in COVID19 patients
100 Clinical Results associated with Allogeneic mesenchymal stem cells therapy (Bonus BioGroup)
100 Translational Medicine associated with Allogeneic mesenchymal stem cells therapy (Bonus BioGroup)
100 Patents (Medical) associated with Allogeneic mesenchymal stem cells therapy (Bonus BioGroup)
100 Deals associated with Allogeneic mesenchymal stem cells therapy (Bonus BioGroup)